Ballew Advisors Inc Invests $219,000 in AbbVie Inc. (NYSE:ABBV)

Ballew Advisors Inc bought a new position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) during the 3rd quarter, according to its most recent 13F filing with the SEC. The fund bought 1,123 shares of the company’s stock, valued at approximately $219,000. Several other institutional investors and hedge funds have also recently added to […]

Leave a Reply

Your email address will not be published.

Previous post Birch Hill Investment Advisors LLC Has $26.45 Million Stake in iShares Core S&P 500 ETF (NYSEARCA:IVV)
Next post Ayrshire Capital Management LLC Has $6.42 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)